Table 2.
Antibiotic sensitivity pattern of bacteria isolated from respiratory specimen of patients with VAP.
| Antibiotics |
Pseudomonas
N (%) |
Enterobacter
N (%) |
Klebsiella
N (%) |
E. coli
N (%) |
Acinetobacter
N (%) |
Stenotrophomonas
N (%) |
Haemophilus
N (%) |
Staphylococcus
N (%) |
Streptococcus
N (%) |
|---|---|---|---|---|---|---|---|---|---|
| Penicillin-G | — | — | — | — | — | — | — | 7 (33.3%) | 3 (60%) |
| Oxacillin | — | — | — | — | — | — | — | 13 (61.9%) | — |
| Ampicillin | — | 0 (0%) | 0 (0%) | 1 (20%) | — | — | 15 (93.8%) | — | — |
| Amoxicillin/clavulanate | — | 0 (0%) | 16 (64%) | 1 (20%) | — | — | 16 (100%) | — | 5 (100%) |
| Piperacillin/tazobactam | 36 (92.3%) | 17 (70.8%) | 20 (80%) | 4 (80%) | 5 (21.7%) | — | — | — | — |
| Cefuroxime | — | 2 (8.3%) | 18 (72%) | 1 (20%) | — | — | 15 (93.8%) | — | — |
| Ceftriaxone | — | 18 (75%) | 18 (72%) | 1 (20%) | — | — | — | — | 5 (100%) |
| Ceftazidime | 33 (84.6%) | — | — | 1 (20%) | 2 (8.7%) | — | — | — | — |
| Cefepime | 34 (87.2%) | — | 18 (72%) | 1 (20%) | 4 (17.4%) | — | — | — | — |
| Clindamycin | — | — | — | — | — | — | — | 19 (90.5%) | 5 (100%) |
| Erythromycin | — | — | — | — | — | — | — | 17 (80.9%) | 5 (100%) |
| Vancomycin | — | — | — | — | — | — | — | 21 (100%) | — |
| Cotrimoxazole | — | 24 (100%) | 17 (68%) | 1 (20%) | 5 (21.7%) | 4 (100%) | 11 (68.8%) | — | — |
| Ciprofloxacin | 36 (92.3%) | 24 (100%) | 24 (96%) | 1 (20%) | 5 (21.7%) | — | — | — | — |
| Levofloxacin | — | — | — | — | — | 3 (75%) | — | — | — |
| Gentamicin | 36 (92.3%) | 24 (100%) | 25 (100%) | 2 (40%) | 5 (21.7%) | — | — | — | — |
| Meropenem | 36 (92.3%) | 23 (95.8%) | 25 (100%) | 5 (100%) | 5 (21.7%) | — | — | — | — |
| Colistin | 39 (100%) | — | — | — | 23 (100%) | — | — | — | — |
|
| |||||||||
| Total number of isolates | 39 | 24 | 25 | 5 | 23 | 4 | 16 | 21 | 5 |